SLFN12 and triple-negative breast carcinoma: In contrast, SLFN12 inhibits ZEB1 translation without transcriptional inhibition, induces CD44+/CD24- stem cell differentiation, and reduces the proliferation of triple negative breast cancer cells but not the ER+/PR+ MCF7 cells [14].